Pharmacokinetics and tumour drug metabolism of anti cancer drugs
Matrix metalloproteinases as targets for tumour-selective delivery of anticancer therapeutics
Drug delivery and prodrug design
Novel advances in analytical techniques. HPLC, GC, CE and LC/MS/MS
Drug interactions both in vitro and in vivo
Roles and Responsibilities
Team Leader: DMPK
Management of DMPK and Clinical Pharmacology Group
Deputy Institute Safety Liaison Officer
Institute local education authority Nuffield placement liaison
Laboratory Coordinator of Phase I clinical trials
Key publications
N. Isambert, M. Campone, E. Bourbouloux, M. Drouin, A. Major, W. Yin, P.M. Loadman, R. Capizzi, C. Grieshaber, P. Fumoleau, "Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours" European Journal of Cancer, (2010), 46, 4, 729-734
Gillian Hawcroft, Paul M. Loadman, Andrea Belluzzi, Mark A Hull, "The effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signalling in human colorectal cancer cells," Neoplasia, (2010);12(8):618-27
Jennifer M Atkinson, Robert A Falconer, Dylan R Edwards, Caroline J Pennington, Catherine S Siller, Steven D Shnyder, Michael C Bibby, Laurence H Patterson, Paul M Loadman, Jason H Gill "Development of a tumor-targeted vascular disrupting agent activated by Membrane-type Matrix Metalloproteinases (MT-MMPs)," Cancer Research, (2010) 70:6902-6912
Daniel Hochhauser, Timothy Meyer, Victoria J Spanswick, Jenny Wu, Peter H Clingen, Paul M. Loadman, Margaret Cobb, Lindsey Gumbrell, Richard H Begent, John A Hartley and Duncan Jodrell "Phase 1 Study Of A Sequence Selective Minor Groove DNA Binding Agent (SJG-136) With Pharmacokinetic And Pharmacodynamic Measurements In Patients With Advanced Solid Tumours," (2009), Clin Cancer Res 15(6): 2140-7
Kaye J. Williams, Mark R. Albertella, Brian Fitzpatrick, Paul M. Loadman, Steven D. Shnyder, Edwin C. Chinje, Brian A. Telfer, Chris R. Dunk, Peter A. Harris and Ian J. Stratford, "In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenograft," (2009), Molecular Cancer Therapeutics, 8(12):3266–75
Albertella M.R., Loadman P.M., Jones P.H., Phillips R.M., Rampling R., Burnet N., Alcock C., Anthoney A., Vjaters E., Dunk C.R., Harris P.A., Wong A., Lalani A.S. and Twelves C.J. "Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase 1 study." (2008), Clinical Cancer Research,14, 1096-1104
Research Team
Amanda Race, Research Technician
Jason Lyle, Research Assistant
Postgraduate student supervision
Mohammed N.Al-andas (Joint supervision with Prof Laurence Patterson) PhD project: Cytochrome P450-activated prodrugs
Ahmed M.M. Youssef (Joint supervision with Dr Rob Falconer and Dr Jason Gill) PhD project: MMP-activated peptide prodrugs
John Hutchinson, University of Leeds (Joint supervision with Prof Mark Hull, University of Leeds and Prof Anna Nicolau, University of Bradford) PhD project: Defining the anti-colorectal cancer activity of Resolvin E1
Hannah Bateson (Joint supervision with Dr Chris Sutton) PhD project: Development of new methods for purifying and characterising membrane proteins from cancer related samples
Hafiz Makeen (Joinr supervision with Dr Roger Phillips) PhD project: Quantitative cancer therapeutics; from model to clinic. Funded by Yorkshire Cancer Research. Award expected 2011
Teaching responsibilities
Lectures:MSc in Cancer Pharmacology
Lectures: BSc. & MSc Final Year: Oncology and Toxicology Module
Lectures: MSc Biomedical Science: Research & Analytical Methods
Lectures: BSc Second Year module: Analytical Biochemistry
Lectures: BSc.& MSc Final Year: Molecular Pharmacology
Guest Lectures University of London
Guest Lectures University of Leeds
Guest Lectures University of Napier
Professional Society Memberships
Member of the British Association for Cancer Research
Member of the Institute of Biology
Member of the American Association for Cancer Research
Member of Pharmacokinetics and Molecular Mechanisms (PAMM) Group, EORTC